Register entry
Supernus Pharmaceuticals Inc
- Registered sites
- 1
- Drug products
- 12
- Live patents
- 151
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testing
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Supernus Pharmaceuticals Inc | Rockville, MDUnited States | Analytical testing | 3005209462 |
Exclusivity
Patents
151Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| GOCOVRI | AMANTADINE HYDROCHLORIDE | Jan 2028 |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | Dec 2030 |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | Jun 2034 |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | Dec 2034 |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | Aug 2038 |
| OSMOLEX ER | AMANTADINE HYDROCHLORIDE | Jan 2028 |
| OSMOLEX ER | AMANTADINE HYDROCHLORIDE | Mar 2030 |
| OSMOLEX ER | AMANTADINE HYDROCHLORIDE | Feb 2038 |
| OXTELLAR XR | OXCARBAZEPINE | Apr 2027 |
| QELBREE | VILOXAZINE HYDROCHLORIDE | Sept 2029 |
| QELBREE | VILOXAZINE HYDROCHLORIDE | Feb 2033 |
| QELBREE | VILOXAZINE HYDROCHLORIDE | Apr 2035 |
| TROKENDI XR | TOPIRAMATE | Nov 2027 |
| TROKENDI XR | TOPIRAMATE | Apr 2028 |
Catalogue
Marketed products
12Showing 12 of 12.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| GOCOVRI | AMANTADINE | CAPSULE, COATED PELLETS | NDA |
| GOCOVRI | AMANTADINE | CAPSULE, COATED PELLETS | NDA |
| OXTELLAR XR | OXCARBAZEPINE | TABLET | NDA |
| OXTELLAR XR | OXCARBAZEPINE | TABLET | NDA |
| OXTELLAR XR | OXCARBAZEPINE | TABLET | NDA |
| QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| QELBREE | viloxazine hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Trokendi XR | topiramate | CAPSULE, EXTENDED RELEASE | NDA |
| Trokendi XR | topiramate | CAPSULE, EXTENDED RELEASE | NDA |
| Trokendi XR | topiramate | CAPSULE, EXTENDED RELEASE | NDA |
| Trokendi XR | topiramate | CAPSULE, EXTENDED RELEASE | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.